Sfoglia per Autore
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging
2004 Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A.
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
2004 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M.
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma
2004 Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
2004 TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M.
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
2005 TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA S; BACCARANI M.; CAVO M.
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
2006 Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L.
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
2006 Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M.
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M.
Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato; G. Montini; S. Fanti.
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Montini; M. Cavo; S. Fanti.
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
2006 Palumbo A; Bringhen S; Caravita T; Merla E; Capparella V; Callea V; Cangialosi C; Grasso M; Rossini F; Galli M; Catalano L; Zamagni E; Petrucci MT; De Stefano V; Ceccarelli M; Ambrosini MT; Avonto I; Falco P; Ciccone G; Liberati AM; Musto P; Boccadoro M; Italian Multiple Myeloma Network; GIMEMA.
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Baccarani M; Cavo M.
Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
2006 Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Cavo M.; Fanti S.
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
2007 Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M.
Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
2007 Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA.
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
2007 Terragna C.; Renzulli M.; Remondini D.; Tagliafico E.; Roncaglia E.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Ceccolini M.; Brioli AM.; Martinelli G.; Baccarani M.; Cavo M.
Prevention of VTE in multiple myeloma patients.
2007 Zamagni E.; Valdrè L.; Palareti G.; Cavo M.
Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM
2007 C. Terragna; M. Renzulli; D. Remondini; E. Tagliafico; E. Roncaglia; P. Tosi; E. Zamagni; P. Tacchetti; G. Perrone; M. Ceccolini; G. Martinelli; M. Baccarani; M. Cavo
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
2007 Cavo M; Tosi P; Zamagni E; Cellini C; Tacchetti P; Patriarca F; Di Raimondo F; Volpe E; Ronconi S; Cangini D; Narni F; Carubelli A; Masini L; Catalano L; Fiacchini M; de Vivo A; Gozzetti A; Lazzaro A; Tura S; Baccarani M.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging | Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; ...Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. | Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Pa...lareti G; Tura S; Baccarani M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P....; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. | TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M. | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma. | TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA ...S; BACCARANI M.; CAVO M. | 2005-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission. | Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Gr...afone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L. | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. | Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; ...Tura S; Baccarani M; Cavo M. | 2006-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini... C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M. | 2006-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato;... G. Montini; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Monti...ni; M. Cavo; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. | Palumbo A; Bringhen S; Caravita T; Merla E; Capparella V; Callea V; Cangialosi C; Grasso M; Rossi...ni F; Galli M; Catalano L; Zamagni E; Petrucci MT; De Stefano V; Ceccarelli M; Ambrosini MT; Avonto I; Falco P; Ciccone G; Liberati AM; Musto P; Boccadoro M; Italian Multiple Myeloma Network; GIMEMA. | 2006-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Baccarani M; Cavo M. | 2006-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. | Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Ca...vo M.; Fanti S. | 2006-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) | Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; ...Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M. | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Neuropathy in multiple myeloma treated with thalidomide: a prospective study. | Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F;... Bartolomei I; Michelucci R; Tassinari CA. | 2007-01-01 | NEUROLOGY | - | 1.01 Articolo in rivista | - |
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) | Terragna C.; Renzulli M.; Remondini D.; Tagliafico E.; Roncaglia E.; Tosi P.; Zamagni E.; Tacchet...ti P.; Perrone G.; Ceccolini M.; Brioli AM.; Martinelli G.; Baccarani M.; Cavo M. | 2007-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Prevention of VTE in multiple myeloma patients. | Zamagni E.; Valdrè L.; Palareti G.; Cavo M. | 2007-01-01 | THROMBOSIS RESEARCH | - | 1.01 Articolo in rivista | - |
Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM | C. Terragna; M. Renzulli; D. Remondini; E. Tagliafico; E. Roncaglia; P. Tosi; E. Zamagni; P. Tacc...hetti; G. Perrone; M. Ceccolini; G. Martinelli; M. Baccarani; M. Cavo | 2007-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. | Cavo M; Tosi P; Zamagni E; Cellini C; Tacchetti P; Patriarca F; Di Raimondo F; Volpe E; Ronconi S...; Cangini D; Narni F; Carubelli A; Masini L; Catalano L; Fiacchini M; de Vivo A; Gozzetti A; Lazzaro A; Tura S; Baccarani M. | 2007-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile